학술논문

Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial
Document Type
Article
Source
In The Lancet Respiratory Medicine November 2021 9(11):1288-1298
Subject
Primary Research
Articles
Language
ISSN
2213-2600